Production of host cells containing mutiple integrating vectors by serial transduction
Details for Australian Patent Application No. 2005208507 (hide)
International Classifications
Event Publications
7 September 2006 PCT application entered the National Phase
PCT publication WO2005/072129 Priority application(s): WO2005/072129
21 May 2009 Alteration of Name
The name of the applicant has been altered to Catalent Pharma Solutions, Inc.
4 June 2009 Application Accepted
Published as AU-B-2005208507
1 October 2009 Standard Patent Sealed
17 March 2011 Assignment Registered
Catalent Pharma Solutions, Inc. The patent has been assigned to Catalent Pharma Solutions, LLC
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005208552-Use of aerosolized antithrombin to treat acute lung injury
2005208501-Method and system for automatically optimizing zone duct damper positions
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser